These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 44374)
21. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. Rao VA; Bishop M; Coppen A Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106 [TBL] [Abstract][Full Text] [Related]
22. Plasma prolactin concentrations and psychopathology in chronic schizophrenia. Kleinman JE; Weinberger DR; Rogol AD; Bigelow LB; Klein ST; Gillin JC; Wyatt RJ Arch Gen Psychiatry; 1982 Jun; 39(6):655-7. PubMed ID: 6979991 [TBL] [Abstract][Full Text] [Related]
23. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels. Johnson GF; Hunt GE Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868 [TBL] [Abstract][Full Text] [Related]
24. Serum prolactin as a correlate of clinical response to haloperidol. Van Putten T; Marder SR; Mintz J J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154 [TBL] [Abstract][Full Text] [Related]
25. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study. Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082 [TBL] [Abstract][Full Text] [Related]
26. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls. Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710 [TBL] [Abstract][Full Text] [Related]
27. Determination of butaperazine in plasma and red blood cells by fluorometry. Dekirmenjian H; Javaid JI; Liskevych U; Davis JM Anal Biochem; 1980 Jun; 105(1):6-13. PubMed ID: 6108731 [No Abstract] [Full Text] [Related]
28. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate. Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812 [TBL] [Abstract][Full Text] [Related]
29. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients. Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605 [TBL] [Abstract][Full Text] [Related]
30. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics. Keskiner A; Itil TM; Todt N Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278 [No Abstract] [Full Text] [Related]
31. Evaluation of butaperazine in chronic schizophrenia. Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043 [No Abstract] [Full Text] [Related]
32. Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate. Jørgensen A; Andersen J; Bjørndal N; Dencker SJ; Lundin L; Malm U Psychopharmacology (Berl); 1982; 77(1):58-65. PubMed ID: 6812119 [TBL] [Abstract][Full Text] [Related]
33. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings. Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339 [TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge. Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731 [TBL] [Abstract][Full Text] [Related]
35. Butaperazine (Repoise). Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275 [No Abstract] [Full Text] [Related]
36. Blood levels of haloperidol in schizophrenic patients. Shvartsburd A; Dekirmenjian H; Smith RC J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528 [TBL] [Abstract][Full Text] [Related]
37. Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients. Osborne M; Crayton JW; Javaid J; Davis JM Biol Psychiatry; 1982 May; 17(5):627-9. PubMed ID: 6124283 [No Abstract] [Full Text] [Related]
38. Clozapine: plasma levels and prolactin response. Kane JM; Cooper TB; Sachar EJ; Halpern FS; Bailine S Psychopharmacology (Berl); 1981; 73(2):184-7. PubMed ID: 6785813 [TBL] [Abstract][Full Text] [Related]
39. Butaperazine and prochlorperazine; a comparative trial of two phenothiazines. Bordeleau JM; Rajotte P; Tétreault L Chemotherapia (Basel); 1964-1965; 9(4):248-58. PubMed ID: 4378567 [No Abstract] [Full Text] [Related]
40. [Comparative study of butaperazine and prochlorperazine for schizophrenia in acute phase]. Albert JM; Rajotte P; Rajotte E; Tétreault L Union Med Can; 1970 Jul; 99(7):1282-5. PubMed ID: 4396306 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]